Literature DB >> 8633607

Case series analysis of adverse reactions to vaccines: a comparative evaluation.

C P Farrington1, J Nash, E Miller.   

Abstract

A modified cohort method has been proposed for estimating the relative incidence of rare adverse reactions after vaccination. The method requires only a sample of the cases, thus avoiding the need for following large population cohorts or selecting controls. This case series method has statistical power equivalent to that of the full cohort method when the risk periods after vaccination are short and vaccine coverage is high. The method also eliminates confounding by variables associated with both the outcome and avoidance of vaccination. In this paper, the cohort, case-control, and case series methods are reviewed, and their underlying assumptions and performances are compared. Theoretical results are illustrated using data on febrile convulsions after measles-mumps-rubella vaccination in the United Kingdom.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633607     DOI: 10.1093/oxfordjournals.aje.a008695

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  53 in total

Review 1.  Vaccine trials.

Authors:  C P Farrington; E Miller
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

2.  Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?

Authors:  L J Tata; J West; T Harrison; P Farrington; C Smith; R Hubbard
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

3.  No evidence of an association between MMR vaccine and gait disturbance.

Authors:  E Miller; N Andrews; A Grant; J Stowe; B Taylor
Journal:  Arch Dis Child       Date:  2005-03       Impact factor: 3.791

4.  Assessing effects of disease genes and gene-environment interactions: the case-spouse design and the counterfactual-control analysis.

Authors:  Wen-Chung Lee; Chin-Hao Chang
Journal:  J Epidemiol Community Health       Date:  2006-08       Impact factor: 3.710

5.  Discussion: An estimate of the science-wise false discovery rate and application to the top medical literature.

Authors:  Martijn J Schuemie; Patrick B Ryan; Marc A Suchard; Zach Shahn; David Madigan
Journal:  Biostatistics       Date:  2013-09-25       Impact factor: 5.899

6.  Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Authors:  Paul E Stang; Patrick B Ryan; J Marc Overhage; Martijn J Schuemie; Abraham G Hartzema; Emily Welebob
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

7.  Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012.

Authors:  Alexander J Millman; Sue Reynolds; Jonathan Duffy; Jufu Chen; Paul Gargiullo; Alicia M Fry
Journal:  Vaccine       Date:  2016-12-29       Impact factor: 3.641

8.  Why collect individual-level vaccination data?

Authors: 
Journal:  CMAJ       Date:  2010-01-04       Impact factor: 8.262

9.  Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions.

Authors:  Anthony Grosso; Ian Douglas; Aroon Hingorani; Raymond MacAllister; Liam Smeeth
Journal:  Br J Clin Pharmacol       Date:  2008-07-31       Impact factor: 4.335

10.  The use of relative incidence ratios in self-controlled case series studies: an overview.

Authors:  Steven Hawken; Beth K Potter; Julian Little; Eric I Benchimol; Salah Mahmud; Robin Ducharme; Kumanan Wilson
Journal:  BMC Med Res Methodol       Date:  2016-09-23       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.